Navigation Links
New Syringe Designed to Position More Large Volume Injectable Drugs for Prefill Administration
Date:8/13/2013

FRANKLIN LAKES, N.J., Aug. 13, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the launch of BD Sterifill Advance™, a new prefillable polymer syringe specially engineered to deliver large volume injectable drugs by way of intravenous infusion.

BD Sterifill Advance™ is a 50 mL plastic prefillable syringe made with a highly advanced cyclic olefin polymer that is designed to offer a number of advantages to drug manufacturers and healthcare professionals including reduced breakage, glass-like transparency, and low levels of extractables.  This unique polymer combined with a specific coating technology provides smooth gliding, ensuring an accurate and consistent infusion rate.

"BD applied our extensive knowledge and experience with prefillable syringes to design this new syringe with properties that support the delivery of large volume injectable drugs, making the advantages of this option more widely available," said Claude Dartiguelongue, President, BD Medical - Pharmaceutical Systems. "We are offering drug developers, healthcare workers and patients a new option for prefill drug delivery that sets new standards in both safety and convenience."

The BD Sterifill Advance™ Plastic Prefillable Syringe aims to provide a seamless transition for healthcare workers in the hospital setting because the syringe was developed from the design of BD Plastipak™, a leading disposable syringe. This unique design avoids any syringe pump reprogramming activity for hospitals and aims to reduce risks of administration errors for healthcare workers. In addition, the syringe has been designed to be highly durable, reducing the probability of flange breakage and ensures a reliable connection with syringe pumps. 

The syringe can address a number of drug delivery needs for the intravenous infusion of large volumes of drugs including: anesthesia, pain management, cardiac therapy and nutrition amongst others. The product can also be used in a variety of settings for parenteral administration of pharmaceutical compounds.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Jamie Yacco
Public Relations
(201) 847-4796
Jamie_Yacco@bd.com


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
2. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
3. BD Announces Agreement to Acquire Safety Syringes, Inc.
4. Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan
5. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
6. Microneedle Drug Patches, Syringes & Systems
7. West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
8. Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects
9. Prefilled Syringes 2013 Market Report
10. Dual Chamber Syringes & Injectors
11. Integrated Safety Syringes to 2016: Devices, Markets Players and Prospects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
Breaking Medicine News(10 mins):